Alerje Brings on Former Pharmaceutical Exec to the Advisory Board
Frank Orlowski brings 25 years of experience in the pharmaceutical industry to Alerje as an investor and strategic advisor. His experience aligns with our current team’s skillsets and we’re excited to have him on board!
Frank’s was happy to share a bit about our latest partnership,
“Epinephrine for a food allergies has been a highly effective treatment helping millions of people around the world for over 25 years. However the critical issue for this therapy has always been the human error, where patients forget to carry their EpiPen and are hospitalized, or even tragically die if not immediately treated.
Alerje is a revolutionary answer to this problem combining the smartphone (which none of us forget to carry!), cutting-edge, informative software, and a medical device — all in one.
I am excited to leverage my 25 years of global Pharmaceutical experience at Pfizer to invest and advise for Alerje — the first technology to integrate smartphones and software, with a life saving medical device — all in one!”
Special thanks to our friends at Solidea Capital for making the connection!
About Frank Orlowski:
Frank is an accomplished Senior Executive and Board Member with more than 25 years of success in the pharmaceutical, medical devices, contract
manufacturing, and healthcare industries. Leveraging extensive experience
leading operational and financial strategies, Frank is a valuable asset for
companies seeking guidance on growth, global markets, cost control, and
capital investment. His broad areas of expertise include international expansion, distribution logistics, contract negotiation, supply reliability, system implementation, change management, acquisitions, divestitures, joint ventures, and team building.
For over 22 years, Frank has worked at Pfizer Inc. in positions of increasing
responsibility in Finance and Operations. He works in a wide range of
environments both internally and externally with the ability to respond to
inquiries quickly in highly-stressed environments. This includes presentations to senior government officials, country management, and economic boards in
India, Japan, Australia, China, and Turkey, as well as presentations to Pfizer’s
Executive Leadership Team and Board of Directors. Through his company’s
major acquisitions of Warner Lambert, Pharmacia and Wyeth Frank has
developed and implemented integrated organizational infrastructure,
processes, and systems. He has also played a leadership role with country
specific acquisitions outside the USA working with international third-party
investment banking groups and other international financial institutions.
